Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Cardiology and Medicine Clinic, PA
mi
from
Little Rock, AR
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Cardiology and Medicine Clinic, PA
mi
from
Little Rock, AR
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
COR Healthcare
mi
from
San Pedro, CA
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
COR Healthcare
mi
from
San Pedro, CA
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Ventura Cardiology Consultants Medical Group, Inc
mi
from
Ventura, CA
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Ventura Cardiology Consultants Medical Group, Inc
mi
from
Ventura, CA
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Wellness Clinical Research, LLC
mi
from
Hialeah Gardens, FL
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Wellness Clinical Research, LLC
mi
from
Hialeah Gardens, FL
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Maya Research Center, Inc
mi
from
Hialeah, FL
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Maya Research Center, Inc
mi
from
Hialeah, FL
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Infinity Clinical Research
mi
from
Plantation, FL
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Infinity Clinical Research
mi
from
Plantation, FL
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Midwest Heart & Vascular Specialists, LLC
mi
from
Overland Park, KA
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Midwest Heart & Vascular Specialists, LLC
mi
from
Overland Park, KA
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Krishnan Challappa M.D. PSC
mi
from
Elizabethtown, KY
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Krishnan Challappa M.D. PSC
mi
from
Elizabethtown, KY
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Long Island Heart Associates
mi
from
Mineola, NY
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Long Island Heart Associates
mi
from
Mineola, NY
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Gotham Cardiovascular Research PC
mi
from
New York, NY
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Gotham Cardiovascular Research PC
mi
from
New York, NY
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
New Bern Internal Medicine
mi
from
New Bern, NC
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
New Bern Internal Medicine
mi
from
New Bern, NC
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Detweiler Family Medicine and Associates, PC
mi
from
Lansdale, PA
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Detweiler Family Medicine and Associates, PC
mi
from
Lansdale, PA
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
Charleston Internal Medicine, Inc.
mi
from
Charleston, WV
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
Charleston Internal Medicine, Inc.
mi
from
Charleston, WV
Click here to add this to my saved trials
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated:  12/31/1969
HealthEast Clinical Trials Office
mi
from
Saint Paul, MN
Patient and Provider Assessment of Lipid Management Registry
Patient and Provider Assessment of Lipid Management Registry
Status: Enrolling
Updated: 12/31/1969
HealthEast Clinical Trials Office
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Bay Regional Medical Center
mi
from
Bay City, MI
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Bay Regional Medical Center
mi
from
Bay City, MI
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
St John Hospital & Medical Center
mi
from
Detroit, MI
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
St John Hospital & Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
University of Virginia Medical Center
mi
from
Charlottesville, VA
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
University of Virginia Medical Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
UCLA Medical Center
mi
from
Los Angeles, CA
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Sharp Memorial Hospital
mi
from
San Diego, CA
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
River City Clinical Research
mi
from
Jacksonville, FL
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
River City Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
UF Health Jacksonville
mi
from
Jacksonville, FL
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
UF Health Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Watson Clinic Center for Research
mi
from
Lakeland, FL
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Watson Clinic Center for Research
mi
from
Lakeland, FL
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Suburban Hospital - John Hopkins Medicine
mi
from
Bethesda, MD
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Suburban Hospital - John Hopkins Medicine
mi
from
Bethesda, MD
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Catholic Medical Center
mi
from
Manchester, NH
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Catholic Medical Center
mi
from
Manchester, NH
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
St. Joseph's Regional Medical Center
mi
from
Paterson, NJ
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
St. Joseph's Regional Medical Center
mi
from
Paterson, NJ
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Mitroflow DL Post Approval Study- North America
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D
Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D
Status: Enrolling
Updated:  12/31/1969
University Hospitals of Cleveland
mi
from
Cleveland, OH
Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D
Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Huntsville, AL
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Washington Township Medical Foundation
mi
from
Fremont, CA
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Washington Township Medical Foundation
mi
from
Fremont, CA
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Reseda, CA
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Reseda, CA
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Orlando Heart Specialists
mi
from
Altamonte Springs, FL
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Orlando Heart Specialists
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Elkhart Clinic, LLC
mi
from
Elkhart, IN
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Minneapolis, MN
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Minneapolis, MN
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Hattiesburg Clinic
mi
from
Hattiesburg, MS
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Hattiesburg Clinic
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Cardiology Associates Research LLC
mi
from
Tupelo, MS
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Cardiology Associates Research LLC
mi
from
Tupelo, MS
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Missouri Cardiovascular Specialists
mi
from
Columbia, MO
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Missouri Cardiovascular Specialists
mi
from
Columbia, MO
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Bryan Heart Hospital
mi
from
Lincoln, NE
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Bryan Heart Hospital
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Asheville Cardiology Associates
mi
from
Asheville, NC
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Asheville Cardiology Associates
mi
from
Asheville, NC
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Upstate Cardiology
mi
from
Greenville, SC
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Upstate Cardiology
mi
from
Greenville, SC
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Carolina Cardiology Clinical Research Institute
mi
from
Rock Hill, SC
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Carolina Cardiology Clinical Research Institute
mi
from
Rock Hill, SC
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Angiocardiac Care of Texas, PA
mi
from
Houston, TX
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Angiocardiac Care of Texas, PA
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Mercury Medical, LLC
mi
from
San Antonio, TX
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Mercury Medical, LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Milwaukee, WI
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Buenos Aires,
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Buenos Aires,
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Manshadi Heart Institute Inc
mi
from
Stockton, CA
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Manshadi Heart Institute Inc
mi
from
Stockton, CA
Click here to add this to my saved trials